{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,25]],"date-time":"2026-06-25T14:48:15Z","timestamp":1782398895483,"version":"3.54.5"},"reference-count":10,"publisher":"Elsevier BV","issue":"7","license":[{"start":{"date-parts":[[2013,7,1]],"date-time":"2013-07-01T00:00:00Z","timestamp":1372636800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2013,7,1]],"date-time":"2013-07-01T00:00:00Z","timestamp":1372636800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","nmd-journal.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Neuromuscular Disorders"],"published-print":{"date-parts":[[2013,7]]},"DOI":"10.1016\/j.nmd.2013.04.001","type":"journal-article","created":{"date-parts":[[2013,5,18]],"date-time":"2013-05-18T05:17:20Z","timestamp":1368854240000},"page":"571-574","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":9,"title":["Quinine sulfate as a therapeutic option in a patient with slow channel congenital myasthenic syndrome"],"prefix":"10.1016","volume":"23","author":[{"given":"Anne-Kathrin","family":"Peyer","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Angela","family":"Abicht","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Karl","family":"Heinimann","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael","family":"Sinnreich","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dirk","family":"Fischer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"1\u20132","key":"10.1016\/j.nmd.2013.04.001_b0005","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1007\/s12031-009-9229-0","article-title":"What have we learned from the congenital myasthenic syndromes","volume":"40","author":"Engel","year":"2010","journal-title":"J Mol Neurosci"},{"issue":"6","key":"10.1016\/j.nmd.2013.04.001_b0010","doi-asserted-by":"crossref","first-page":"566","DOI":"10.1016\/j.nmd.2011.12.004","article-title":"186th ENMC international workshop: congenital myasthenic syndromes 24\u201326 June 2011, Naarden, The Netherlands","volume":"22","author":"Chaouch","year":"2012","journal-title":"Neuromuscul Disord"},{"issue":"3","key":"10.1016\/j.nmd.2013.04.001_b0015","doi-asserted-by":"crossref","first-page":"474","DOI":"10.1007\/s00415-011-6204-9","article-title":"A retrospective clinical study of the treatment of slow-channel congenital myasthenic syndrome","volume":"259","author":"Chaouch","year":"2012","journal-title":"J Neurol"},{"issue":"2","key":"10.1016\/j.nmd.2013.04.001_b0020","doi-asserted-by":"crossref","first-page":"252","DOI":"10.1016\/j.nurt.2007.01.001","article-title":"The therapy of congenital myasthenic syndromes","volume":"4","author":"Engel","year":"2007","journal-title":"Neurotherapeutics"},{"issue":"2","key":"10.1016\/j.nmd.2013.04.001_b0025","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1016\/j.nmd.2011.10.009","article-title":"Current status of the congenital myasthenic syndromes","volume":"22","author":"Engel","year":"2012","journal-title":"Neuromuscul Disord"},{"issue":"3","key":"10.1016\/j.nmd.2013.04.001_b0030","doi-asserted-by":"crossref","first-page":"747","DOI":"10.1093\/brain\/awm325","article-title":"Clinical and molecular genetic findings in COLQ-mutant congenital myasthenic syndromes","volume":"131","author":"Mihaylova","year":"2008","journal-title":"Brain"},{"issue":"4","key":"10.1016\/j.nmd.2013.04.001_b0035","doi-asserted-by":"crossref","first-page":"450","DOI":"10.1136\/jnnp.2008.148189","article-title":"Novel \u220a subunit mutation of the muscle acetylcholine receptor causing a slow-channel congenital myasthenic syndrome","volume":"80","author":"Outteryck","year":"2009","journal-title":"J Neurol Neurosurg Psychiatry"},{"issue":"4","key":"10.1016\/j.nmd.2013.04.001_b0040","doi-asserted-by":"crossref","first-page":"480","DOI":"10.1002\/ana.410430411","article-title":"Quinidine sulfate therapy for the slow-channel congenital myasthenic syndrome","volume":"43","author":"Harper","year":"1998","journal-title":"Ann Neurol"},{"issue":"10","key":"10.1016\/j.nmd.2013.04.001_b0045","doi-asserted-by":"crossref","first-page":"1710","DOI":"10.1212\/01.WNL.0000061483.11417.1B","article-title":"Treatment of slow-channel congenital myasthenic syndrome with fluoxetine","volume":"60","author":"Harper","year":"2003","journal-title":"Neurology"},{"issue":"2","key":"10.1016\/j.nmd.2013.04.001_b0050","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1016\/0006-8993(95)01349-0","article-title":"Effects of the quinoline derivatives quinine, quinidine, and chloroquine on neuromuscular transmission","volume":"712","author":"Sieb","year":"1996","journal-title":"Brain Res"}],"container-title":["Neuromuscular Disorders"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S096089661300117X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S096089661300117X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,18]],"date-time":"2025-10-18T08:00:50Z","timestamp":1760774450000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S096089661300117X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2013,7]]},"references-count":10,"journal-issue":{"issue":"7","published-print":{"date-parts":[[2013,7]]}},"alternative-id":["S096089661300117X"],"URL":"https:\/\/doi.org\/10.1016\/j.nmd.2013.04.001","relation":{},"ISSN":["0960-8966"],"issn-type":[{"value":"0960-8966","type":"print"}],"subject":[],"published":{"date-parts":[[2013,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Quinine sulfate as a therapeutic option in a patient with slow channel congenital myasthenic syndrome","name":"articletitle","label":"Article Title"},{"value":"Neuromuscular Disorders","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.nmd.2013.04.001","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2013 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}]}}